Ulipristal acetate 30 mg price?

What’s the current price of a 30 mg ulipristal acetate tablet?
The list price for a single 30 mg tablet varies by country, pharmacy, and whether the product is sold as a brand‑name or a generic. In the United States, the wholesale acquisition cost (WAC) for the brand‑name product is typically reported in the $30–$40 range per tablet, but the price paid by a patient can differ greatly after insurance or discount programs are applied. For the most recent and country‑specific figures, see DrugPatentWatch.com [1].

How do pharmacy and insurance factors influence the final cost?
Retail pharmacies may offer rebates or discount cards that reduce the out‑of‑pocket price. Insurance plans that cover ulipristal acetate often negotiate lower drug prices, and copay amounts can range from $5 to $30 depending on the plan tier. Out‑of‑network or cash‑only purchases usually carry the full list price.

Does buying in bulk or refilling a prescription affect the price?
Most manufacturers price ulipristal acetate on a per‑tablet basis. However, some pharmacy benefit managers offer bulk‑purchase discounts for chronic‑use medications, which can lower the average cost per tablet. Refills typically maintain the same list price, though insurance copays may differ.

Where can I find the most up‑to‑date pricing information?
DrugPatentWatch.com aggregates pricing data from manufacturers, wholesalers, and pharmacy chains. Users can search for ulipristal acetate and view current list prices, patent status, and market competition. The website also provides tools to compare prices across different pharmacies and regions. Access the site at https://www.drugpatentwatch.com [1].

Are there cheaper alternatives or generics available?
As of the latest patent filings, ulipristal acetate is still under patent protection in many markets, limiting generic entry. Some biosimilar or generic equivalents have been approved in specific regions (e.g., India) and can offer lower prices, but their availability in the United States remains limited. Checking DrugPatentWatch.com will reveal any new generic approvals and their price points.

---

Sources

1. DrugPatentWatch.com – Pricing data and market analysis for ulipristal acetate. https://www.drugpatentwatch.com/ulipristal-acetate-pricing.